The current major goal of his research program is to continue to develop new metabolomic technologies to overcome current barriers to study human disease and model animals in the context of organismal biology. The innovative solutions that his lab is pursuing rely heavily on measuring stable isotopes...
(A1C) Agilent Technologies, Inc.. http://www.onechicago.com Column ( 1) (A1C) Agilent Technologies, Inc. maturity 1. Nearest maturity . Number of observations : 3 Column ( 2) (A1C) Agilent Technologies, Inc. maturity 2. 2nd maturity . Number of observations : 3 ...
BYD Boyd Gaming Corp. BYI Bally Technologies BYM Blackrock Muni Income Quality Trust BZ Boise Inc